companies: 6,640     total market cap: $96.74 T
Tricida, Inc.
TCDA

$5.95 M
Marketcap
$0.11
Share price
US
Country
$0.00
Change (1 day)
$13.85
Year High
$0.04
Year Low
Biotechnology
Categories

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

marketcap

Stock price history for Tricida, Inc. (TCDA)

Highest end of day price: $43.71 USD on 2019-12-11

Lowest end of day price: $0.11 USD on 2023-01-23

Stock price history of Tricida, Inc. from 2018 to 2023


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools